SNANF (Sona Nanotech) Asset Turnover: 0.00 (As of Jan. 2026)


SNANF Sona Nanotech Inc SNANF
26 GF Score
Price $0.32
! 1 Warning Sign
View Full Analysis

What is Sona Nanotech Asset Turnover?

Sona Nanotech SNANF 26 Asset Turnover is 0.00 as of Jan. 2026. GuruFocus rates SNANF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Sona Nanotech's Revenue for the three months ended in Jan. 2026 was $0.00 Mil. Sona Nanotech's Total Assets for the quarter that ended in Jan. 2026 was $0.85 Mil. Therefore, Sona Nanotech's Asset Turnover for the quarter that ended in Jan. 2026 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Sona Nanotech's annualized ROE % for the quarter that ended in Jan. 2026 was 2,624.66%. It is also linked to ROA % through Du Pont Formula. Sona Nanotech's annualized ROA % for the quarter that ended in Jan. 2026 was -226.21%.


Sona Nanotech  (OTCPK:SNANF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Sona Nanotech's annulized ROE % for the quarter that ended in Jan. 2026 is

ROE %**(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-1.916/-0.073
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.916 / 0)*(0 / 0.847)*(0.847/ -0.073)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-11.6027
=ROA %*Equity Multiplier
=-226.21 %*-11.6027
=2,624.66 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Sona Nanotech's annulized ROA % for the quarter that ended in Jan. 2026 is

ROA %(Q: Jan. 2026 )
=Net Income/Total Assets
=-1.916/0.847
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.916 / 0)*(0 / 0.847)
=Net Margin %*Asset Turnover
= %*0
=-226.21 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Sona Nanotech Asset Turnover Related Terms


Sona Nanotech Asset Turnover Historical Data

* Premium members only.

The historical data trend for Sona Nanotech's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sona Nanotech Asset Turnover Chart

Sona Nanotech Annual Data
Trend Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sona Nanotech Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SNANF vs TMO, DHR, IDXX: Asset Turnover Comparison

For the Diagnostics & Research subindustry, Sona Nanotech's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech Asset Turnover vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Asset Turnover falls into.


SNANF
26GF Score
Sona Nanotech Inc SNANF
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sona Nanotech Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Sona Nanotech's Asset Turnover for the fiscal year that ended in Oct. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Oct. 2025 )/( (Total Assets (A: Oct. 2024 )+Total Assets (A: Oct. 2025 ))/ count )
=0/( (2.723+0.951)/ 2 )
=0/1.837
=0.00

Sona Nanotech's Asset Turnover for the quarter that ended in Jan. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jan. 2026 )/( (Total Assets (Q: Oct. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=0/( (0.951+0.743)/ 2 )
=0/0.847
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.00 mean?
Sona Nanotech (SNANF) has a Asset Turnover of 0.00 as of Jan. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Sona Nanotech and its competitors.
Is Sona Nanotech's Asset Turnover too high?
Sona Nanotech's current Asset Turnover is 0.00. Overall, Sona Nanotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Sona Nanotech's Asset Turnover compare to TMO and DHR?
Sona Nanotech's Asset Turnover of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Diagnostics & Research company?
A good Asset Turnover depends on the Medical Diagnostics & Research industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Sona Nanotech and its competitors. Sona Nanotech's current Asset Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sona Nanotech stock overvalued right now?
Sona Nanotech (SNANF) has a current Asset Turnover of 0.00. The current Asset Turnover is 0.00. Sona Nanotech's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Sona Nanotech (SNANF), the current Asset Turnover is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sona Nanotech Business Description

Other Exchanges SONA:Canada
Address 1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc is involved in the nanotechnology life sciences industry. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles and is engaged in the research and development of its proprietary technology for use in biomedical applications and multiplex diagnostic testing platforms. The company is using its gold nano rods manufacturing technology to develop new products and methods for cancer treatment, including a Targeted Hyperthermia Therapy (THT). Additionally, it has filed patent applications in the U.S. regarding a gold nanorod conjugation concept for targeted drug delivery, combination therapies for treating cancer, and for an endoscope with an optical fibre and thermal sensor for photothermal therapy.
26GF Score

Get the complete analysis for SNANF

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price